{
    "id": "0142",
    "question": "A 67-year-woman with non-Hodgkin lymphoma comes to the physician because of progressively increasing numbness and tingling in her fingers and toes. Her last cycle of chemotherapy with vincristine was 1 week ago. Physical examination shows decreased sensation to light touch in all distal extremities. Knee and ankle deep tendon reflexes are decreased. Which of the following is the most likely underlying mechanism of this patient\u2019s peripheral neuropathy?",
    "options": {
        "A": "Inhibition of beta-tubulin polymerization",
        "B": "Creation of free radicals that unwind DNA",
        "C": "Inhibition of dihydrofolate reductase",
        "D": "Incorporation of false pyrimidine analogues into DNA"
    },
    "answer": "A",
    "predict": "To solve this question, let's break down the information and analyze it step by step: 1. **Patient's symptoms and history**: The patient has non-Hodgkin lymphoma and has recently completed a cycle of chemotherapy with vincristine. The symptoms she's experiencing are numbness, tingling, decreased sensation to light touch in distal extremities, and decreased knee and ankle deep tendon reflexes. 2. **Vincristine's mechanism of action**: Vincristine is a vinca alkaloid, which works by inhibiting microtubule polymerization. Microtubules are essential for the transport of proteins and organelles within the cell, including those involved in nerve function. By inhibiting microtubule polymerization, vincristine disrupts axonal transport, leading to neurotoxicity. 3. **Peripheral neuropathy mechanism**: The symptoms described are characteristic of a peripheral neuropathy, which involves damage to the peripheral nerves. Given vincristine's mechanism of action, the most likely underlying mechanism of this patient's peripheral neuropathy is the inhibition of microtubule polymerization. 4. **Analyzing the options**: - A. Inhibition of beta-tubulin polymerization: This option directly aligns with vincristine's mechanism of action, which involves inhibiting microtubule polymerization. - B. Creation of free radicals that unwind DNA: This mechanism is more characteristic of alkylating agents, such as cyclophosphamide. - C. Inhibition of dihydrofolate reductase: This is the mechanism of action of methotrexate, a different class of chemotherapeutic agents. - D. Incorporation of false pyrimidine analogues into DNA: This is the mechanism of action of fluoropyrimidines, such as 5-fluorouracil. Based on the analysis, the most likely underlying mechanism of this patient's peripheral neuropathy is the inhibition of microtubule polymerization, which is associated with vincristine. **Output**: ```json {\"step_by_step_thinking\": \"The patient's symptoms and history, combined with vincristine's mechanism of action, suggest that the peripheral neuropathy is caused by the inhibition of microtubule polymerization. This is the most likely underlying mechanism of this patient's peripheral neuropathy.\", \"answer_choice\": \"A\"} ```",
    "snippets": [],
    "scores": [],
    "execution_time": 30.46820044517517
}